Who Paid My Doc
Dasiglucagon
Device Type I Diabetus
General payments
$59,762
Research payments
$55,201
Through program year 2020, $59,762 in general payments and $55,201 in research payments were reported against Dasiglucagon (Type I Diabetus).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $59,762 | 17 |
| 2020 | Research | $55,201 | 9 |
Breakdown
The top 5 of 13 recipients; each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 10 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
17 general · 9 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.